Literature DB >> 2143013

Platelet function in sickle cell disease during steady state.

P Triadou1, E Fonty, A S Ambrosio, M C Cottat, R Girot, P Cornu.   

Abstract

Platelet function was investigated in 37 patients with sickle cell disease during steady state. The measurement of platelet aggregation in whole blood, demonstrating interaction of sickle cells and platelets, showed increased activity in patients compared to controls. In contrast, by classical platelet aggregation in platelet-rich plasma (PRP) we observed decreased platelet aggregation in sickle cell patients. Aggregation of washed platelets appeared identical in patients and controls beta thromboglobulin (beta TG) and platelet factor 4 (PF4) as well as fibrinopeptide A (FPA) plasma levels were increased in patients with sickle cell disease. These results suggest that in sickle cell patients there is in vivo platelet stimulation, which may therefore appear "exhausted" in patients plasma during in vitro studies, and also a possible role of coagulation in the pathophysiology of sickle cell disease as supported by high levels of FPA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143013

Source DB:  PubMed          Journal:  Nouv Rev Fr Hematol


  4 in total

1.  Inflammation in sickle cell disease.

Authors:  Nicola Conran; John D Belcher
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

2.  Which adults with sickle cell disease need an evaluation for pulmonary embolism?

Authors:  Nadirah El-Amin; Steven D Lauzon; Paul J Nietert; Julie Kanter
Journal:  Br J Haematol       Date:  2021-09-01       Impact factor: 6.998

3.  Endothelial activation by platelets from sickle cell anemia patients.

Authors:  Renata Proença-Ferreira; Ana Flávia Brugnerotto; Vanessa Tonin Garrido; Venina Marcela Dominical; Daiana Morelli Vital; Marilene de Fátima Reis Ribeiro; Melissa Ercolin dos Santos; Fabíola Traina; Sara T Olalla-Saad; Fernando Ferreira Costa; Nicola Conran
Journal:  PLoS One       Date:  2014-02-13       Impact factor: 3.240

Review 4.  Biomarkers and recent advances in the management and therapy of sickle cell disease.

Authors:  Marilyn J Telen
Journal:  F1000Res       Date:  2015-10-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.